lung and breast cancer detection

Bio & Pharma Celltrion unveils cancer medicine to expand new drug pipelines

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...

Bio & Pharma SillaJen: First to use lab-grown human tissue to find best cancer drug dose

South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determine the best dose for a cancer drug combination in clinical tria...

Regulations S.Korea needs to allow short-selling for all listed stocks: FSS chief

Lee Bok-hyun, governor of South Korea’s top financial watchdog body, the Financial Supervisory Service (FSS), said on Thursday that there shou...

Bio & Pharma Celltrion’s Vegzelma: Most-prescribed cancer treatment in Europe

South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...

Bio & Pharma Yuhan’s lung cancer drug gets OK in Europe

Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...

Korean startups TALOS dives deeper into brain aneurysm icebergs

 A single neurosurgeon dedicates his or her entire professional career to performing surgeries on an average of fewer than 10,000 patients with...

Bio & Pharma President of Latvia visits S.Korea's Daan Cancer Lab

Daan Cancer Laboratory under Severance Hospital said on Thursday it signed a memorandum of understanding (MOU) with the Latvian government to streng...

Bio & Pharma Korea’s Lunit in AI-powered lung cancer diagnostics deal with AstraZeneca

Lunit Inc., a South Korean AI-powered cancer diagnostics company, has partnered with global biopharma giant AstraZeneca plc. to jointly enter the AI...

Bio & Pharma Volpara to supply breast cancer SW to US Defense Health Agency

Lunit, a South Korean cancer diagnostics AI company, said on Monday its US subsidiary Volpara Health secured a 10 billion won ($7.5 million) contr...

Tech, Media & Telecom LG Elec to advance in-cabin sensing solution

LG Electronics Inc. said on Monday it's advancing its in-cabin sensing solution which detects and analyzes the interior of vehicles to prevent acc...

Automobiles Kia releases 2025 model year of Carnival

Kia Corp., South Korea’s second-largest automaker, said on Monday it will release The 2025 Carnival, a model year of its large recreational ve...

Bio & Pharma Celltrion's anti cancer drugs hold 90% market share in C.America

South Korea’s Celltrion Inc. said on Friday that its cancer treatments have captured a 90% market share in several Central American countries....

Artificial intelligence KT to develop AI tech to filter spam messages

South Korea's KT Corp. said on Tuesday it will work with the Korea Internet & Security Agency (KISA) to launch an artificial intelligence (AI)...

Bio & Pharma Celltrion to supply breast, stomach cancer treatment to Brazil

Celltrion Inc., South Korea’s largest biosimilar maker, announced on Friday that its breast and stomach cancer treatment "Herzuma" (active ing...

Human Interest After 37 years of use, Kim returns trusty microwave to Samsung with love

For 37 years, a simple microwave made by Samsung Electronics Co. sat in the kitchen of Kim Kyu-won, providing much more than convenience.It was ther...

Tech, Media & Telecom KT applies AIoT video surveillance to EV charging stations

South Korea's KT Corp. said on Monday that it will expand its Artificial Intelligence Internet of Things (AIoT) video surveillance business to elect...

Bio & Pharma SK Group’s 3rd-generation daughter comes to the fore

Chey Yoon-chung, the eldest daughter of SK Group Chairman Chey Tae-won, unexpectedly made her debut during an SK Biopharmaceuticals Co. video confer...

Bio & Pharma Gencurix, Hitachi to cooperate on molecular diagnostics

South Korean biotech company Gencurix Inc. said on Tuesday that it will cooperate with Japan's Hitachi High-Tech Corporation to enter the Japanese c...

Bio & Pharma Volpara to supply cancer diagnostics SW to Intermountain Health

Lunit, a South Korean cancer diagnostics AI company, announced on Wednesday that its subsidiary Volpara Health, a New Zealand-based AI software deve...

Bio & Pharma Yuhan’s lung cancer drug clears FDA hurdle for global debut

A new lung cancer treatment developed by South Korea’s Yuhan Corp. has secured approval from the US Food and Drug Administration (FDA) as a co...

Tech, Media & Telecom SK Telecom, Nokia to cooperate on AI-based network tech

South Korea's SK Telecom Co. announced on Monday that it signed a memorandum of understanding (MOU) with Nokia to commercialize the wired network AI...

Bio & Pharma Lunit to supply AI cancer diagnostics to Qatar

Lunit Inc., a South Korean cancer diagnostics AI company, announced on Monday that it will provide its AI breast cancer screening solution Lunit Ins...

Robotics Lotte Innovate releases autonomous security robot Dooroo Eye

South Korea's Lotte Innovate will unveil its autonomous security robot, Dooroo Eye, at the upcoming Autonomous Driving Mobility EXPO 2024, the com...

Artificial intelligence Lunit eyes developing markets with AI cancer diagnostics

Lunit Inc., a South Korean cancer diagnostics AI company, will accelerate its inroads into developing markets grappling with inadequate cancer diagn...

Artificial intelligence AI plagiarism detection startup Muhayu eyes IPO in 2026

South Korean artificial intelligence (AI) startup Muhayu hired Mirae Asset Securities as the lead manager for its initial public offering (IPO) targ...

Bio & Pharma JLK gets FDA OK for prostate cancer diagnosis AI solution

South Korea’s JLK Inc., an AI-based diagnosis solution and platform maker, announced on Monday that it got approval from the US Food and Drug ...

Bio & Pharma Korean biotech Bertis to join BIO 2024 for global reach

South Korean biotech Bertis Inc. will deliver presentations at the BIO International Convention, one of the world’s largest bio and healthcare...

Mergers & Acquisitions Lunit buys breast cancer detection AI firm Volpara Health

Lunit Inc., a South Korean cancer diagnostics AI company, has completed the acquisition of Volpara Health Technologies Ltd., a New Zealand-based AI ...

Bio & Pharma Investors dump Korean biotech HLB stocks on FDA rejection

HLB Co. and its affiliate stocks tumbled on Friday on news that the South Korean biotech group’s highly anticipated new cancer treatment Rivoc...

Bio & Pharma Celltrion to supply Remsima, Herzuma to Peru

South Korea's Celltrion Inc. announced on Thursday that it secured a contract to supply its biosimilars for autoimmune disease treatment and antican...